glp 1 lilly Eli to seek approval of new GLP-1 weight-loss drug this year GLP-1 weight loss could soon
Description
Learn how and why GLP-1 medications work

Doctor-trusted GLP-1 for Weight Loss

Not intended for individuals under 18, pregnant or nursing individuals, or anyone with a known medical condition or taking medication including GLP-1 medications
Ascletis ASC35, a once-monthly GLP-1/GIP peptide using a self-assembling lipid depot, cleared FDA IND for Phase 1 head-to-head vs weekly tirzepatide June 23.
Despite these encouraging findings, further research is still needed to understand more thoroughly the mechanisms by which GLP-1RAs may mediate stroke protection specifically in the human diabetic brain.

Semaglutide: Tirzepatide is a dual agonist for GLP-1 and GIP receptors
